Northwire Canada EditionWednesday, July 15, 2026
Northwire
LIF 27.02 −0.7% CPAU 0.155 +0.0% PTX 0.110 +0.0% VENT 0.160 +0.0% ANK 0.280 −3.5% ODV 3.32 −1.5% MINK 0.105 +0.0% ZEN 0.670 +4.7% LCE 0.250 +4.2% CBA 0.085 +0.0% SGU 0.040 +0.0% COSA 0.610 −1.6% DML 4.42 −0.9% MTT 0.150 +0.0% LME 0.190 +2.7% SVM 13.19 −0.1% LIF 27.02 −0.7% CPAU 0.155 +0.0% PTX 0.110 +0.0% VENT 0.160 +0.0% ANK 0.280 −3.5% ODV 3.32 −1.5% MINK 0.105 +0.0% ZEN 0.670 +4.7% LCE 0.250 +4.2% CBA 0.085 +0.0% SGU 0.040 +0.0% COSA 0.610 −1.6% DML 4.42 −0.9% MTT 0.150 +0.0% LME 0.190 +2.7% SVM 13.19 −0.1%
M&A / Property Material +

Urano and Pegasus Receive Shareholder and Court Approval for Acquisitions by Aero; Name Change to Manhattan Uranium Discovery Corp. Effective May 7, 2026

Manhattan Uranium Deal Clears Hurdles as Pegasus Emerges from Regulatory Limbo

Executive Summary
  • The most recent announcement (May 4, 2026) confirms that Aero Energy Limited has received shareholder and court approval to acquire Urano Energy Corp. and Pegasus Resources Inc. via plans of arrangement.
  • The Supreme Court of British Columbia granted a final order on May 4, 2026.
  • Aero Energy Limited is changing its name to Manhattan Uranium Discovery Corp., with the new ticker symbol "MANU" expected to trade starting May 7, 2026.
  • Closing is expected on or about May 7, 2026, subject to customary conditions.
  • Historical context shows Pegasus Mercantile was previously facing a Failure-to-File Cease Trade Order (FFCTO) which was revoked in March 2026 after filing audited statements for FY2025.
  • Prior to the M&A approval, Pegasus engaged in multiple debt settlements (December 2025 and March 2026) issuing shares at a deemed price of $0.05 to settle liabilities owed to directors and third parties.
Material Impact
  • Regulatory Clearance: The court and shareholder approvals remove the immediate existential risk associated with the FFCTO and trading suspension that plagued the company in early 2026. This is a material positive development for liquidity and investor confidence.
  • Strategic Pivot: The rebranding to Manhattan Uranium Discovery Corp. signifies a fundamental shift from Pegasus's previous diversified focus (wellness, psychedelics, healthcare) to a pure-play uranium exploration vehicle. This aligns with current market themes but introduces execution risk regarding the quality of Aero's assets.
  • Valuation Floor: The consistent debt settlement price of $0.05 per share in late 2025 and early 2026 establishes a psychological floor for the stock, which is currently trading at this level ($0.05).
  • Dilution Concerns: The history of settling debt with equity (e.g., CA$163k for 3.2M shares in March 2026) indicates significant dilution and cash flow constraints prior to the merger. While the deal resolves this, existing shareholders may face further dilution depending on the exchange ratio not detailed in the release.
  • Risk Mitigation: The completion of the arrangement mitigates the risk of bankruptcy or prolonged delisting that was present during the FFCTO period (February-March 2026).
LOAN · Price
Company Overview
  • Company Overview: Pegasus Mercantile Inc. was previously a diversified resource and wellness company. Following the May 2026 arrangement, it will operate as Manhattan Uranium Discovery Corp., focusing on uranium exploration.
  • Flagship Project: The specific flagship project details for the new entity are not fully disclosed in the provided news, but the acquisition involves Aero Energy Limited's assets. Previously, Pegasus held an LOI (January 2026) to acquire Omega Gold Corp.'s Rio Bravo gold claims in Peru, though this appears superseded by the broader Uranium-focused merger.
  • Development: The company has moved from a distressed state (FFCTO, debt settlements) to a restructured entity with court-approved M&A.
Read the original news release →

More from Pegasus Mercantile Inc.